{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:04:39Z","timestamp":1757700279020,"version":"3.33.0"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T00:00:00Z","timestamp":1170720000000},"content-version":"vor","delay-in-days":67,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Skinmed"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p><jats:italic>Systemic agents such as methotrexate and cyclo\u2010sporine are commonly used in the treatment of psoriasis. Long\u2010term continuous use is not recommended due to potential organ toxicity, myelosuppression, and carcinogenicity. Abrupt cessation of systemic agents without tapering can lead to flare\u2010up and rebound of psoriasis. The addition of a biologic agent during transitional therapy from a systemic agent is a good strategic maneuver to prevent a potential rebound complication. Even with a gradual cessation of systemic agents, the psoriasis will eventually relapse if biologic agents are not added to the treatment regimen. No additional toxicities or adverse events are evident during combination therapy with a systemic agent and a biologic agent.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1540-9740.2006.05679.x","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T23:52:07Z","timestamp":1170805927000},"page":"285-290","source":"Crossref","is-referenced-by-count":16,"title":["A Treatment Strategy for Psoriasis: Transitioning From Systemic Therapy to Biologic Agents"],"prefix":"10.1111","volume":"5","author":[{"given":"Arisa","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"iii37","DOI":"10.1136\/ard.60.90003.iii37","article-title":"Cytokine blockers in psoriatic arthritis","volume":"60","author":"Mease PJ","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120568"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80313-2"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01134-4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.5.657"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7493.716"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-004-2003-6"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030409"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1627"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030002"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.127247"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb02161.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30050-0"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70508-0"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)80237-8"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101313240501"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70325-1"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.2.361"},{"volume-title":"Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology","year":"1822","author":"Yamauchi PS","key":"e_1_2_5_20_2"},{"volume-title":"Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology","year":"1822","author":"Yamauchi PS","key":"e_1_2_5_21_2"}],"container-title":["SKINmed: Dermatology for the Clinician"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-9740.2006.05679.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-9740.2006.05679.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T16:04:13Z","timestamp":1736784253000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-9740.2006.05679.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1540-9740.2006.05679.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-9740.2006.05679.x","archive":["Portico"],"relation":{},"ISSN":["1540-9740","1751-7125"],"issn-type":[{"type":"print","value":"1540-9740"},{"type":"electronic","value":"1751-7125"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}